China’s Path to STEMI Care: Integrated Model Cuts Deaths Nearly in Half

Chinese scientists have conducted a landmark prospective, multicentre, non-randomised controlled trial demonstrating that an integrated care model can substantially improve outcomes for patients with ST-segment elevation myocardial infarction (STEMI) in China. The study, published in Heart, enrolled 6,817 patients across eight tertiary hospitals from August 2015 to February 2019, comparing an intervention group receiving a comprehensive integrated care strategy with a control group receiving standard care.

The integrated care model focused on community public education about heart attack symptoms, specialised training for healthcare workers in hospitals without percutaneous coronary intervention (PCI) capabilities, improved referral systems, and optimized emergency channels at PCI-capable centres. Results showed that the proportion of patients receiving symptom-to-reperfusion within 12 hours rose dramatically from 65.3% to 91.4% in the intervention group. More strikingly, rates of in-hospital mortality and major adverse cardiac events decreased by nearly onefold. This suggests that the prehospital phase is a critical and addressable bottleneck in STEMI care, especially for patients in remote or medically underserved regions.

Why it matters:
For health systems facing resource constraints, this model offers an evidence-based pathway to dramatically improve cardiac emergency outcomes without requiring expensive new infrastructure. The study underscores that systematic, community-level interventions addressing patient delays and inter-hospital coordination can be as impactful as advanced technology. This has global relevance as STEMI remains a leading cause of death worldwide, and China’s success offers a replicable template for other nations grappling with similar geographic and economic disparities in healthcare access.

Source →